Literature DB >> 15252116

cAMP-induced degradation of cyclin D3 through association with GSK-3beta.

Soheil Naderi1, Kristine B Gutzkow, Hege U Låhne, Siri Lefdal, W Johnathan Ryves, Adrian J Harwood, Heidi K Blomhoff.   

Abstract

In this study we report a new mechanism whereby cyclic AMP (cAMP) regulates the cell-cycle machinery. We demonstrate that elevation of intracellular levels of cAMP promotes degradation of cyclin D3 in proteasomes, and that this occurs via glycogen synthase kinase-3beta (GSK-3beta)-mediated phosphorylation of cyclin D3 at Thr-283. Elevation of cAMP did not change the subcellular distribution of either cyclin D3 or GSK-3beta. However, cAMP promoted the interaction between cyclin D3 and GSK-3beta both in vitro and in vivo, indicating that GSK-3beta-mediated phosphorylation of cyclin D3 might require the association between the two proteins. These results demonstrate how cAMP enhances degradation of cyclin D3. Furthermore, we provide evidence for a novel mechanism by which GSK-3beta might phosphorylate unprimed substrates in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15252116     DOI: 10.1242/jcs.01210

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  28 in total

1.  mTORC1 activation regulates beta-cell mass and proliferation by modulation of cyclin D2 synthesis and stability.

Authors:  Norman Balcazar; Aruna Sathyamurthy; Lynda Elghazi; Aaron Gould; Aaron Weiss; Ichiro Shiojima; Kenneth Walsh; Ernesto Bernal-Mizrachi
Journal:  J Biol Chem       Date:  2009-01-14       Impact factor: 5.157

Review 2.  Cyclin D degradation by E3 ligases in cancer progression and treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  Semin Cancer Biol       Date:  2020-01-30       Impact factor: 15.707

3.  Adenomatous polyposis coli protein associates with C/EBP beta and increases Bacillus anthracis edema toxin-stimulated gene expression in macrophages.

Authors:  Jason L Larabee; Salika M Shakir; Logan Hightower; Jimmy D Ballard
Journal:  J Biol Chem       Date:  2011-04-12       Impact factor: 5.157

4.  GSK3β mediates muscle pathology in myotonic dystrophy.

Authors:  Karlie Jones; Christina Wei; Polina Iakova; Enrico Bugiardini; Christiane Schneider-Gold; Giovanni Meola; James Woodgett; James Killian; Nikolai A Timchenko; Lubov T Timchenko
Journal:  J Clin Invest       Date:  2012-11-19       Impact factor: 14.808

Review 5.  Molecular mechanisms of muscle atrophy in myotonic dystrophies.

Authors:  Lubov Timchenko
Journal:  Int J Biochem Cell Biol       Date:  2013-06-21       Impact factor: 5.085

6.  Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility.

Authors:  Courtney R Lavalle; Karla Bravo-Altamirano; Karthik V Giridhar; Jun Chen; Elizabeth Sharlow; John S Lazo; Peter Wipf; Q Jane Wang
Journal:  BMC Chem Biol       Date:  2010-05-05

7.  Cyclin D2 protein stability is regulated in pancreatic beta-cells.

Authors:  Lu Mei He; Daniel J Sartori; Monica Teta; Lynn M Opare-Addo; Matthew M Rankin; Simon Y Long; J Alan Diehl; Jake A Kushner
Journal:  Mol Endocrinol       Date:  2009-07-23

8.  Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment.

Authors:  Michelle Mo; Ildiko Erdelyi; Klara Szigeti-Buck; Jennifer H Benbow; Barbara E Ehrlich
Journal:  FASEB J       Date:  2012-08-13       Impact factor: 5.191

9.  Bacillus anthracis edema toxin activates nuclear glycogen synthase kinase 3beta.

Authors:  Jason L Larabee; Kevin DeGiusti; James L Regens; Jimmy D Ballard
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

10.  The age-associated decline of glycogen synthase kinase 3beta plays a critical role in the inhibition of liver regeneration.

Authors:  Jingling Jin; Guo-Li Wang; Xiurong Shi; Gretchen J Darlington; Nikolai A Timchenko
Journal:  Mol Cell Biol       Date:  2009-04-27       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.